Scholars Central

Short communicationPublished 31 Jul 2020

Commentary on Endometriosis Recurrence Management.

Authors: Abo Taleb Saremi

Critical Care Obstetrics and Gynecology

Volume 6 · Issue 3 · Pages 4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Medical treatment of endometriosis ranges from symptomatic control to therapies aimedat suppressing the ovarian production of estrogen.Almost all the treatment strategies are suppressive rather than curative so that the discontinuation of therapy leads to recurrence of symptoms. In 2009, a systematic review of literature estimated the recurrence rate of endometriosis to be 21.5% and 40%-50% within two and five years, respectively [1], which is much more prevalent than previously believed. Regrowth of residual lesions and de novo lesion formation are possible pathogenesis mechanisms leading to the recurrenceof endometrial lesions. Radical surgery means the elimination of all possible endometriosis implants detected in pelvic and abdominal cavity, that is sometimes insufficient to radically remove these lesions; therefore, lesions often reappear postoperatively.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Critical Care Obstetrics and Gynecology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCritical Care Obstetrics and Gynecology
  • SubjectReproductive Medicine & Gynaecology
  • SubjectAnaesthesia & Pain
  • BylineArticles whose byline prints “Abo Taleb Saremi”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels